Cancer Biomarkers Funding Opportunities

Title Announcement # Expiration Datesort descending
Program to Assess the Rigor and Reproducibility of Exosome-Derived Analytes for Cancer Detection PAR-16-276 (R01) 06/14/2019
Innovative Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-019 (R21 Clinical Trials Not Allowed) 09/28/2019
Innovative Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-021 (R21 Clinical Trials Not Allowed) 09/28/2019
Advanced Development and Validation of Emerging Biospecimen Science Technologies for Basic and Clinical Cancer Research RFA-CA-19-022 (R33 Clinical Trials Not Allowed) 09/28/2019
Advanced Development and Validation of Emerging Molecular and Cellular Analysis Technologies for Basic and Clinical Cancer Research RFA-CA-19-020 (R33 Clinical Trials Not Allowed) 09/28/2019
Academic-Industrial Partnerships to Translate and Validate in vivo Cancer Imaging Systems PAR-18-009 (R01 Clinical Trial Optional) 11/06/2019
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH2/UH3 - Clinical Trials Not Allowed) PAR-18-317 10/09/2020
Assay Validation of High Quality Markers for Clinical Studies in Cancer (UH3 - Clinical Trials Not Allowed PAR-18-310 10/09/2020
Oncology Co-Clinical Imaging Research Resources to Encourage Consensus on Quantitative Imaging Methods and Precision Medicine PAR-18-841 (U24 - Clinical Trial Optional) 06/15/2021
Advancing Translational and Clinical Probiotic/Prebiotic and Human Microbiome Research PA-18-902 (R01 Clinical Trial Optional) 09/08/2021
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-252 (R21 Clinical Trial Optional) 11/09/2021
Basic and Translational Research on Adducts in Cancer Risk Identification and Prevention PAR-19-251 (R01 Clinical Trial Optional) 11/09/2021
Cancer Tissue Engineering Collaborative: Enabling Biomimetic Tissue-Engineered Technologies for Cancer Research PAR-19-113 (R01 Clinical Trial Optional) 01/08/2022